MaryjoJLechowiczMD
Hematology • Atlanta, GAHematologic Oncology
Professor, Hematology and Medical Oncology, Emory University School of Medicine
Dr. Lechowicz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-1900
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2000 - 2003
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1996 - 2000
SUNY Upstate Medical UniversityClass of 1996
Certifications & Licensure
GA State Medical License 2003 - 2025
MD State Medical License 2000 - 2004
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Valproic Acid in Treating Patients With Kaposi's Sarcoma Start of enrollment: 2005 Feb 01
- Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
- Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma Start of enrollment: 2011 Jun 21
- Join now to see all
Publications & Presentations
PubMed
- Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry.Sheila K Pierson, Joshua D Brandstadter, Drew Torigian, Adam Bagg, Mary Jo Lechowicz
Blood Advances. 2025-02-14 - ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain
Transplantation and Cellular Therapy. 2024-11-01 - 5 citationsLongitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.Mateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, Adam Bagg, Joshua D Brandstadter
Haematologica. 2024-07-01
Abstracts/Posters
- Final Results of Phase 1/1b Study of Tenalisib, Dual PI3K _/_ Inhibitor in Patients with Relapsed/Refractory T-Cell LymphomaMary Jo Lechowicz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Evaluation of Maintenance Therapy in Cutaneous T-Cell Lymphoma Patients Receiving Total Skin Electron Beam Radiation Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
